DFS | DSOS | |||||
---|---|---|---|---|---|---|
p Value | RR | 95% CI | p Value | RR | 95% CI | |
CI, confidence interval; NS, not significant; RR, relative risk. | ||||||
Patients who died without documented disease recurrence (n = 11) were considered censored for disease free survival, but were excluded for disease specific overall survival analysis. | ||||||
DFS, disease free survival; DSOS, disease specific overall survival. | ||||||
Nodal status | 0.005 | 2.1 | 1.2 to 3.4 | 0.002 | 2.6 | 1.4–4.7 |
TN overexpression | 0.03 | 2.0 | 1.1 to 3.9 | 0.02 | 2.3 | 1.1–4.6 |
Tumour size | ||||||
<2 cm v 2–5 cm | NS | NS | ||||
<2 cm v >5 cm | 0.02 | 3.1 | 1.2 to 7.8 | 0.02 | 3.0 | 1.2–7.7 |
Histological grade | 0.02 | 1.8 | 1.0 to 3.9 | 0.001 | 2.6 | 1.5–4.5 |
I+II v III | ||||||
Progesterone receptor | NS | NS | ||||
Oestrogen receptor | NS | NS |